Related Experiment Video
Updated: Oct 12, 2025

Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
Rare primary pulmonary angiosarcoma with aberrant neuroendocrine differentiation.
Gianna N DiGrazia1, Shuchi Zinzuwadia2, Alessa P Aragao3
1Department of Radiology, Loyola University Medical Center, 2160 S. 1st Ave., Maywood, IL 60153, United States of America.
Primary pulmonary angiosarcoma, a rare cancer, can exhibit unusual neuroendocrine traits. This case highlights a unique subtype associated with longer survival, warranting further study.
Area of Science:
- Oncology
- Pathology
- Medical Imaging
Background:
- Angiosarcomas are rare, aggressive endothelial tumors, comprising <1% of soft tissue sarcomas.
- Primary pulmonary angiosarcoma is exceptionally rare, often presenting as metastatic disease with a poor prognosis.
- Diagnosis is challenging due to rarity and low clinical suspicion.
Observation:
- This report details a rare case of primary pulmonary angiosarcoma with aberrant neuroendocrine differentiation.
- Diagnostic imaging, pathological findings, and management strategies are discussed.
- The patient experienced a longer survival period.
Findings:
- The neuroendocrine pathologic subtype may be linked to improved survival, though few cases are documented.
- Aberrant neuroendocrine differentiation in pulmonary angiosarcoma is a unique finding.
Implications:
- Further research is needed to recognize and investigate this rare subtype.
- Identifying diagnostic markers and effective treatments for pulmonary angiosarcoma with neuroendocrine differentiation is crucial.
- Establishing a potential link between this subtype and enhanced survival outcomes is warranted.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023